Filing Flows › OptimizeRx (OPRX) › Q4 2025
OptimizeRx (OPRX) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 12, 2026
OptimizeRx (OPRX) reported revenue of $32.2M for the fourth quarter 2025 (Q4 2025), -0.2% from a year earlier and +24% from the quarter before. Operating margin was 26.6%, net earnings $5.0M (15.6% of revenue).
OptimizeRx, Q4 2025: revenue $32.2M (-0.2% year over year), operating margin 26.6%, net earnings $5.0M, operating cash flow $7.1M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.2M | +24% | -0.2% |
| Gross profit | $24.1M | +38% | +9% |
| Operating profit | $8.6M | +318% | +136% |
| Net earnings | $5.0M | +544% | — |
| Operating cash flow | $7.1M | +121% | 36× |
| Free cash flow | $7.1M | +122% | 39× |
What changed
Revenue was $32.2M in Q4 2025, roughly flat year over year and up 24% from the previous quarter.
Gross margin was 74.8%, up 6.6 points from Q4 2024. Operating profit was $8.6M, a 26.6% margin (up 15.3 points year over year). Operating expenses fell 16% while revenue was flat. Net earnings were $5.0M. The effective tax rate was 32.8%.
Operating cash flow was $7.1M (up 3480% year over year), 141% of net earnings. Non-cash charges added back $1.1M of depreciation and amortization and $2.0M of share-based compensation. Working capital and other items used $1.0M. Capital expenditures of $11K left free cash flow of $7.1M.
Questions
What was OptimizeRx's revenue in the fourth quarter 2025?
OptimizeRx (OPRX) reported revenue of $32.2M for the fourth quarter 2025 (Q4 2025), -0.2% from a year earlier and +24% from the quarter before.
Was OptimizeRx profitable in the fourth quarter 2025?
Operating profit was $8.6M (26.6% of revenue) and net earnings $5.0M.
Source: OptimizeRx 10-K on SEC EDGAR.